Fig. 1From: Gender differences in clinical and prescribing characteristics of biologic and targeted synthetic drugs in naïve patients with rheumatoid arthritis: Data from BIOBADASER III registryKaplan–Meier curve: time course from RA diagnosis until the first prescription of b/tsDMARDBack to article page